[{"uuid": "81ac6689-68ba-3433-9c84-3c9f41cedf2d", "title": "Join Calidi Biotherapeutics\u2019 Exclusive Live Investor Webinar and Q&A Session on February 5", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/join-calidi-biotherapeutics-exclusive-live-130000510.html", "providerPublishTime": 1738155600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/2aK7GW04qPybB7CII7CWkA--~B/aD0yNzM7dz04ODI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 882, "height": 273, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/72zXm9ert10ppQMWfUrSFA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CLDI", "CLDWW"]}, {"uuid": "218016c8-01e7-361e-ab15-7301f18a5374", "title": "Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/calidi-biotherapeutics-announces-bolstered-cash-130000331.html", "providerPublishTime": 1738069200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/2aK7GW04qPybB7CII7CWkA--~B/aD0yNzM7dz04ODI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 882, "height": 273, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/72zXm9ert10ppQMWfUrSFA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CLDI", "CLDWW"]}, {"uuid": "cf573dfd-4995-3857-b7f5-6ee21797a818", "title": "Calidi Biotherapeutics Announces Presentation of New Data of Systemic Virotherapy RTNova Platform at the AACR Annual Meeting in April 2025", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/calidi-biotherapeutics-announces-presentation-data-130000826.html", "providerPublishTime": 1736773200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/2aK7GW04qPybB7CII7CWkA--~B/aD0yNzM7dz04ODI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 882, "height": 273, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/72zXm9ert10ppQMWfUrSFA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CLDI", "CLDWW"]}, {"uuid": "4fec6da0-b4b9-34b8-864c-346d0c521e88", "title": "Calidi Biotherapeutics Prices $4.25 Million Stock Offering; Shares Fall Pre-Bell", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/calidi-biotherapeutics-prices-4-25-142627233.html", "providerPublishTime": 1736519187, "type": "STORY"}, {"uuid": "63e4d33f-b64a-35c4-b3eb-09c0d464fbe4", "title": "Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/calidi-biotherapeutics-announces-closing-4-213000805.html", "providerPublishTime": 1736544600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/2aK7GW04qPybB7CII7CWkA--~B/aD0yNzM7dz04ODI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 882, "height": 273, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/72zXm9ert10ppQMWfUrSFA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CLDI", "CLDWW"]}, {"uuid": "9e4471ee-1d53-371a-ab1c-a1a0a5670f80", "title": "Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/calidi-biotherapeutics-announces-pricing-4-133000100.html", "providerPublishTime": 1736515800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/2aK7GW04qPybB7CII7CWkA--~B/aD0yNzM7dz04ODI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 882, "height": 273, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/72zXm9ert10ppQMWfUrSFA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CLDI", "CLDWW"]}, {"uuid": "4dae940d-3e7b-30a0-a55c-06c8d164a55d", "title": "Calidi Biotherapeutics Announces Proposed Public Offering", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/calidi-biotherapeutics-announces-proposed-public-210100625.html", "providerPublishTime": 1736370060, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/2aK7GW04qPybB7CII7CWkA--~B/aD0yNzM7dz04ODI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 882, "height": 273, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/72zXm9ert10ppQMWfUrSFA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CLDI", "CLDWW"]}, {"uuid": "de98f72a-c284-331b-b903-8c209c8c0a12", "title": "Calidi Biotherapeutics Presents Data Supporting RTNova Systemic Technology to Target Metastatic Lung Cancer", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/calidi-biotherapeutics-presents-data-supporting-130000419.html", "providerPublishTime": 1731934800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/2aK7GW04qPybB7CII7CWkA--~B/aD0yNzM7dz04ODI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 882, "height": 273, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/72zXm9ert10ppQMWfUrSFA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CLDI", "CLDWW"]}, {"uuid": "01f40264-8a3a-318b-95fa-c08959336642", "title": "Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/calidi-biotherapeutics-announces-pricing-7-133000673.html", "providerPublishTime": 1731591000, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/2aK7GW04qPybB7CII7CWkA--~B/aD0yNzM7dz04ODI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 882, "height": 273, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/72zXm9ert10ppQMWfUrSFA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CLDI", "CLDWW"]}, {"uuid": "514314e7-7fed-3164-a127-0e3c3b667da6", "title": "Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/calidi-biotherapeutics-announces-closing-7-210500461.html", "providerPublishTime": 1731704700, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/2aK7GW04qPybB7CII7CWkA--~B/aD0yNzM7dz04ODI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 882, "height": 273, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/72zXm9ert10ppQMWfUrSFA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CLDI", "CLDWW"]}, {"uuid": "2e5f573c-6797-3a82-9ec5-6c579b1ab2b3", "title": "Top Midday Decliners", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/top-midday-decliners-193753666.html", "providerPublishTime": 1731613073, "type": "STORY", "relatedTickers": ["BRAG"]}, {"uuid": "e8f1ce23-037e-3f47-98b2-c86b4189f237", "title": "Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/calidi-biotherapeutics-reports-third-quarter-222900004.html", "providerPublishTime": 1731450540, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/2aK7GW04qPybB7CII7CWkA--~B/aD0yNzM7dz04ODI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 882, "height": 273, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/72zXm9ert10ppQMWfUrSFA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/7d704f48e72f79f78ddf2658e92deb06", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CLDI", "CLDWW"]}]